What Could the Long Term Effects Be With the Newly Approved Tirzepatide Drug? (Guest: Rodney Varner)
Over the years, we’ve seen a number of treatments to help fight back against diabetes. However, a new drug approved by the U.S. Food and Drug Administration could have some interesting effects for the future. Per this report from CNN Health, the newly approved Tirzepatide, sold under the brand name Mounjaro, went through various testing phases for people without diabetes, including doses from 5 to 15 milligrams. Dr. Ania Jastreboff, co-director for the Yale Center … Read more
